

HCW Biologics reports positive Phase 1 data for HCW9302, with all 2nd-cohort alopecia patients showing a clinical response.
You can purchase shares of HCW Biologics (NASDAQ:HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
HCW Biologics has a consensus price target of $30.00.
The stock price for HCW Biologics (NASDAQ: HCWB) is $0.78 last updated November 16, 2026 at 7:00 AM EST.
There are no upcoming dividends for HCW Biologics.
HCW Biologics does not have any upcoming earnings scheduled.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that...